Author:
Dzyuba Sergei V.,Jameson Laramie P.,Nakanishi Koji
Reference71 articles.
1. Abad MJ, Bedoya LM, Bemejo P (2010) An update on drug interactions with the herbal medicine Ginkgo biloba. Curr Drug Metab 11:171–181
2. Bate C, Salmona M, Williams A (2004) Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42. J Neuoroinflammation. http://www.jneuroinflammation.com/content/1/1/4
3. Bate C, Tayebi M, Williams A (2008) Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro. Mol Neurodegeneration 3:1. http://www.molecularneurodegeneration.com/content/3/1/1
4. Bisel P, Al-Momani L, Muller M (2008) The tert-butyl group in chemistry and biology. Org Biomol Chem 6:2655–2665
5. Bolshakov S, Dzyuba SV, Nakanishi K (2006) A concise synthesis of ginkgolide M, a minor component of a terpene trilactone fraction from Ginkgo biloba roots. J Nat Prod 69:429–431